Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CAS gets US grant for adult brain oxygen monitor:

This article was originally published in Clinica

Executive Summary

CAS Medical Systems has gained a $1m US grant to continue its development of a noninvasive device for measuring brain oxygenation in adults. The National Institutes of Health award will be used to refine the product, which is based on near-infrared spectroscopy (NIRS). It will also be used to test and construct pre-manufacturing prototypes. The system will include a monitoring device incorporating proprietary algorithms and a patient sensor that is placed on the forehead. It will enable a rapid indication of absolute brain blood oxygenation saturation and, indirectly, brain circulatory haemodynamic changes, providing healthcare workers with information to guard against neurological injuries due to compromised brain oxygenation, which can often occur during many surgical and clinical situations. The Branford, Connecticut firm also has a phase II grant to apply the technology to neonates.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT058588

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel